FDA Clears Capillus In-Clinic Laser Therapy Hair Growth Device

A new device designed to be used as a part of a programme to combat Androgenic Alopecia in clients visiting hair loss clinics or doctors' offices has been cleared by the Food and Drug Administration in America.

Free-standing LLT device

The Freestanding Capillus272 OfficePro LLLT Device

The Capillus 272 OfficePro is a free-standing variation on existing Low Level Laser Therapy (LLLT) devices. It follows on from the Miami-based company's Capillus 272 cap device, which is designed to be used at home.

According to Capillus, its OfficePro has shown 'the capability to increase hair growth by improving circulation and cellular metabolism in and around hair follicles' in a matter of weeks. Furthermore, for the test subjects, the level of 'patient confidence and scalp health' is also said to have improved over time.

This type of laser therapy is becoming increasingly popular for both men and women with genetic hair loss - more commonly known as Male Pattern Baldness or Female Pattern Hair Loss.

Many new products have been developed in this area recently, including helmet-styles like the iGrow and the Theradome which emit LLLT directly through the hair to the scalp. This works by increasing circulation and boosting cellular metabolism in the scalp, in order to boost hair growth.

However, the original, award-winning HairMax LaserComb holds an additional patent in relation to its combing technique, which allows the laser's rays easier, more direct access to the scalp, rather than just the hair.

Although LLLT will not treat hairloss on its own, it can prove a beneficial regrowth boosting companion to clinically-proven hair loss treatment courses by helping the topical treatment minoxidil to circulate effectively.

Builds relationship between hair loss specialist and client

Clinical Therapy Treatment Can Help to Build the Relationship Between Client and Hair Loss Specialist

Given other efficient LLLT products already exist, including ones which can be used both in-clinic and at-home by clients, what prompted the company to develop this latest medical device?

Capillus says in a press statement that offering an LLLT hair therapy product specifically for use in hair loss clinics or other treatment centres was particularly constructive as it can 'help physicians guide men and women along their journey to a fuller head of natural hair'.

Carlos Piña, Capillus CEO, explains: "Physicians love the OfficePro because it introduces patients to laser hair therapy in the office... It is a wonderful tool for physicians to build a relationship with patients while administering treatment and monitoring results.”

Having a one-to-one session with a hair loss specialist is undeniably a valuable experience for anyone concerned about thinning hair; indeed, LLLT plays a pivotal role in some of Belgravia's clinical therapy treatment sessions. This intimate service allows trust to build between the client and the advisor, and also allows for any issues to be addressed straight away. From advice about using treatments or hair washing, to tweaking treatment course components to ensure clients are always on the most effective and suitable courses at any given time, particularly as their lifestyle changes, it can be a huge relief for clients to have someone to talk to about their concerns.

About FDA clearance for LLLT devices

Capillus was granted a 510(k) clearance by the FDA for its 272 OfficePro model. This relates to the safety and effectiveness of new medical devices and FDA clearance must be obtained before they are introduced to the market.

The HairMax LaserComb is also FDA cleared for use by both men and women, and these are provided free of charge to Belgravia clients when they purchase annual treatment plans.

The company's medical director, Dr. Shelly Friedman, said of the news:“The clearance substantiates what we have known and experienced clinically". Referring to a recent independently reviewed study of the Capillus272 laser cap which reportedly found an increase of 51% in the hair counts of male and female test subjects, she added: "Capillus is very successful in converting fine, vellus hairs to normal growing hairs.”

For more information on at-home or in-clinic LLLT hair growth boosters, please contact the clinic on 020 7730 6666 or send us a message.

Copy of New Street Ground Floor Reception 1 no pink nail polish

The Belgravia Centre

The Belgravia Centre is a world-renowned group of a hair loss clinic in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation from anywhere in the world for home-use treatment.

View our Hair Loss Success Stories, which includes the world's largest gallery of hair growth photos and demonstrates the level of success that so many of Belgravia's patients achieve.

belgravia logo



Do you have a question you would like the Belgravia Specialist to answer?

Related posts